The 340b drug discount program white paper

Download Mitigate Risk, Embrace Opportunity to learn how tech-based solutions can resolve these conflicts, ensure contract pharmacy compliance and enable all stakeholders to collaborate for a successful B program and the good of patients. By submitting this form, I agree that Kalderos may contact me at the email address or phone number above to tell me about its services.

Resources Library. Conducts due diligence and internal investigations and audits and responding to criminal fraud and abuse investigations. Advises clients on public and private policies on issues arising under Medicare and Medicaid, including coding, coverage, and payment.

Advises pharmaceutical manufacturers regarding federal pricing issues under B, the Federal Supply Schedule, Medicare, and Medicaid. Skip to main content. New Articles. January 13, U. Arandia, Jr. Spooner U. Malveaux and Melanie L. Burd and Jeri L. Kinder and Jonathan D. Wohlwend U. Reyes and Jed M. Jones, Jr. Massey and William A.

Bailey and John F. Tzall U. Guerin and S. Tel: Fax: Email: info powerslaw. All rights reserved. Hit enter to search or ESC to close. Leave a Reply Cancel Reply You must be logged in to post a comment. There were large differences in B growth by route of administration, with IV-administered products growing As in , growth of the B program was driven by disease areas containing high-priced specialty products including targeted oncology drugs e.

See Analysis Methods for additional details. Year-on-year sales growth for the ten largest disease areas based on total sales, vs In the previously published IQVIA report 1 , we described the rise of contract pharmacies, and how they're overtaking the traditional B model of delivering drugs through hospital outpatient pharmacies and clinics.

Total sales i. Although the data did not indicate any such relationship results not shown , there are several known caveats with available COVID data, including inconsistent testing across geographies, low capture of asymptomatic and mild infections, and incomplete death counts 5.